PCG- Apothekary SPV, LLC has announced a new private equity offering aimed at raising $2 million, as detailed in their recent SEC filing. The company has already successfully sold $425,000 of this offering, indicating a strong initial interest from investors. This move is significant as it highlights the ongoing demand for private investment opportunities, particularly in the pooled investment fund sector.

PCG- Apothekary SPV, LLC, incorporated in Delaware, operates as a limited liability company. The firm is based in Los Gatos, California, and was established in 2026. The company is classified under the pooled investment fund industry, which encompasses various investment strategies and structures.

The filing states that the offering is made under Rule 506(b), which provides a safe harbor for private offerings. The total offering amount is set at $2 million, with $425,000 already sold and $1,575,000 remaining. The company has not disclosed its revenue range, and it has not accepted investments from non-accredited investors, indicating a focus on high-net-worth individuals.

This fundraising effort may impact various stakeholders, including the seven investors who have already committed funds. The absence of sales commissions or finder’s fees suggests that the company is managing the offering internally, which could enhance the net proceeds available for investment.

The filing does not say what happens next, leaving questions about potential future offerings or the use of proceeds from this round of fundraising.